<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=(0073)file://C:\WINDOWS\Temporary%20Internet%20Files\OLKC225\A0007-1-A2-00.html -->
<HTML><HEAD><TITLE></TITLE>
<META http-equiv=Content-Type content="text/html; charset=windows-1252">
<META content="Microsoft FrontPage 4.0" name=GENERATOR>
<META content=FrontPage.Editor.Document name=ProgId></HEAD>
<BODY bgColor=#cccccc>
<DIV align=center>
<TABLE borderColor=#003366 cellSpacing=5 borderColorDark=#003366 cellPadding=14
width=550 borderColorLight=#003366 border=2>
<TBODY>
<TR>
<TD width="100%" bgColor=#ffffff>
<P class=MsoBodyText align=center><B><FONT face=Verdana color=#003399
size=4>Help Beta Test Our Site and Be Eligible to Purchase Shares of
Future IPOs In Which We Participate**</FONT></B></P>
<P class=MsoBodyText style="TEXT-ALIGN: left" align=left><FONT face=Arial
size=2>eMedsecurities has selected you as a possible participant to help
test our online stock-trading engine for knowledge-based investing in the
life sciences. For your cooperation, <B>you will be eligible to purchase
shares of future IPOs</B> in which we participate, for as long as you
maintain your account with us. This is limited to only <B>50 qualified
testers! </B><a href="mailto:emedemed1@libero.it">Request More
Information</a>.**</FONT></P>
<P class=MsoBodyText align=center><B><FONT face=Verdana color=#003399
size=3>eMedsecurities… The Cure for the Common Portfolio!</FONT></B></P>
<P class=MsoBodyText style="TEXT-ALIGN: left" align=left><FONT face=Arial
size=2>eMedsecurities provides you with a wealth of information, all
compiled in a single, easy-to-use resource. Learn about new research
and upcoming treatments for diabetes, glaucoma, cataract, obesity and much more. Obtain critical investment information about the
companies that are developing these treatments. eMedsecurities empowers
you to make more informed investment decisions. <a href="mailto:emedemed1@libero.it">Request
More Information</a>.**</FONT></P>
<P class=MsoNormal><B><FONT face=Arial size=2>Participation in
eMedsecurities's Beta Test allows you:</FONT></B></P>
<UL>
<LI>
<P class=MsoNormal
style="mso-list: l1 level1 lfo2; tab-stops: list .5in; line-height: 100%; margin-top: 0; margin-bottom: 0"><B><FONT
face=Arial size=2 color="#003399">Eligibility to purchase shares of IPOs in which
eMedsecurities participates for as long as you maintain your
account**</FONT></B> </P>
<LI>
<P class=MsoNormal
style="mso-list: l1 level1 lfo2; tab-stops: list .5in; line-height: 100%; margin-top: 0; margin-bottom: 0"><B><FONT
face=Arial size=2 color="#003399">Valuable research of the entire product
pipeline of companies, including stages of clinical development, by
industry or specific disease</FONT></B> </P>
<LI>
<P class=MsoNormal
style="mso-list: l1 level1 lfo2; tab-stops: list .5in; line-height: 100%; margin-top: 0; margin-bottom: 0"><B><FONT
face=Arial size=2 color="#003399">Useful information about industry trends, recent
developments and upcoming IPOs</FONT></B> </P>
<LI>
<P class=MsoNormal
style="mso-list: l1 level1 lfo2; tab-stops: list .5in; line-height: 100%; margin-top: 0; margin-bottom: 0"><B><FONT
face=Arial size=2 color="#003399">Commitment to customer service featuring
our Live Customer Service Online</FONT></B> </P>
<LI>
<P class=MsoNormal
style="mso-list: l1 level1 lfo2; tab-stops: list .5in; line-height: 100%; margin-top: 0; margin-bottom: 0"><B><FONT
face=Arial size=2 color="#003399">Dedication to fast trade executions at the best
possible price.</FONT></B> </P>
</UL>
<P align=left><FONT face=Arial size=2>The following guidelines will
explain what we expect from an eMedsecurities Beta Tester:</FONT></P>
<UL>
<LI>
<P align=left style="line-height: 100%; margin-top: 0; margin-bottom: 0"><FONT face=Arial size=2>Open a funded eMedsecurities
account</FONT> </P>
<LI>
<P align=left style="line-height: 100%; margin-top: 0; margin-bottom: 0"><FONT face=Arial size=2>Visit our online trading site once
a week</FONT> </P>
<LI>
<P align=left style="line-height: 100%; margin-top: 0; margin-bottom: 0"><FONT face=Arial size=2>Execute trades through our
Web
site in accordance with your normal practice</FONT> </P>
<LI>
<P align=left style="line-height: 100%; margin-top: 0; margin-bottom: 0"><FONT face=Arial size=2>Submit feedback to eMedsecurities's development team through a questionnaire sent via
email</FONT> </P>
<LI>
<P align=left style="line-height: 100%; margin-top: 0; margin-bottom: 0"><FONT face=Arial size=2>Provide us with additional
feedback regarding the site as needed.</FONT> </P></LI></UL>
<P align=left><FONT face=Arial size=2>The test is limited to only 50 Beta
Testers so sign up now to be considered! <a href="mailto:emedemed1@libero.it">Request
More Information</a>.**</FONT>
<P align=left><B><FONT face=Arial size=2>Please note:</FONT></B><FONT
face=Arial size=2> All applications for the Beta Test must be submitted by
January 25, 2001 to be considered.</FONT>
<P align=left><FONT face=Arial size=2><SPAN
style="mso-bidi-font-size: 12.0pt; mso-fareast-font-family: Times New Roman; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">Please
be advised that your information will stay in our proprietary database and
will not be sold, traded, given or otherwise provided to outside vendors.
We respect your privacy.</SPAN></FONT>
<P align=left>
<P align=left><FONT face=Arial size=1><SPAN
style="mso-fareast-font-family: Times New Roman; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">By
submitting your information, you implicitly state that this is something
that interests you and that you<br>
agree to receive periodic emails from
eMedsecurities.</SPAN></FONT>
<P class=MsoNormal><FONT face=Arial size=1>Research indicated that you
might benefit from our offer. To be removed instantly and permanently from
our database, simply <a href="mailto:emed22@libero.it">click here</a>.
We respect
all removal requests.</FONT></P><FONT face=Arial size=1>**<B> Restrictions
Apply:</B> <SPAN style="COLOR: red"><B>Beta test not open to residents
of HI, IL, MI, MN, NE, NH, TN, TX.</B></SPAN> Initial Public
Offerings are considered speculative investments and as such may not be
appropriate for every investor. If an investor chooses to participate in
IPOs, there are certain restrictions that apply. <B><SPAN
style="COLOR: red">Flipping </SPAN>- </B>The first time an investor sells
their shares within the first 30 days the issue is trading in the
secondary market, that investor will not be allocated shares for the next
90 days following the sale. The second time that investor “flips,"
they will not be allocated IPO shares for 180 days. The third time
that investor “flips," they lose their IPO allocations permanently.<SPAN
style="COLOR: red"> <B>Transferring shares</B></SPAN><B><span style="color: red">
</span>- </B>If the
investor transfers IPO shares out of their account within the first 30
days the issue is trading in the secondary market, they will permanently
lose their IPO allocations. <B>Beta investors will be chosen from
all the applicants based on their income, net worth and investing
experience. </B> Beta Test open only to those 21 years of age or
older. IPO shares will only be allocated from transactions in
which eMedsecurities participates in the underwriting. A0009-1-A2</FONT>
<p><FONT face=Arial size=1>
eMedsecurities, Inc. Member NASD SIPC. </FONT></p>
</TD></TR></TBODY></TABLE></DIV></BODY></HTML>